Search company, investor...

Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
ambu.com

Partners & Customers

10

About Ambu

Ambu (AMBU-B.CO) develops, produces, and markets diagnostic and life-supporting devices for hospitals and rescue services, focusing on respiratory support, external cardiopulmonary resuscitation, and basic and advanced resuscitation training. Ambu was formerly known as Testa Laboratory. It was founded in 1937 and is based in Ballerup, Denmark.

Headquarters Location

Baltorpbakken 13

Ballerup, DK-2750,

Denmark

+45 7225 2000

Want to inform investors similar to Ambu about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Ambu News

Disposable Endoscope Market Size Report (Application & End User) to Grow at 16.9% CAGR During (2022-2028)

May 11, 2023

Companies Covered Boston Scientific Corp, Ambu AS, Consis Medical Ltd, Hill-Rom Services Inc, Karl Storz SE & Coo KG, Flexicare (Group) Ltd, OBP Medical Corp, Parburch Medical Developments Ltd, Prosurg Inc, Coloplast Corp Key Research Capabilities Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development Browse key market insights spread across 153 pages with 57 list of tables & 67 list of figures from the report, "Disposable Endoscope Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Urologic Endoscopy, GI Endoscopy, Bronchoscopy, Arthroscopy, Proctoscopy, and Others) and End User (Hospitals, Diagnostic Centers, and Clinics)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/disposable-endoscope-market Rapid Technological Advancements and Product Launches to Fuel Global Disposable Endoscope Market Growth During (2022-2028) The earliest generation of single-use endoscopes demonstrated their clinical value regarding cross contamination, availability, and workflow, but a performance gap compared to reusable endoscopes limited their adoption. However, in recent years, rising technological advancements in sensors, image processing software, and monitor processing power have improved image resolutions and clinical performance of single-use endoscopy products. Moreover, with single-use endoscopes, product iterations can occur at a faster pace than with reusable endoscopes. As a result, a few single-use endoscopes being launched recently have surpassed reusable endoscopes in terms of performance. In July 2020, Ambu A/S launched aScope Duodeno 1.5 single-use duodenoscope for Endoscopic retrograde cholangiopancreatography (ERCP) procedures. The aScope Duodeno 1.5 is designed with high-definition imagery and flexible bending angles to view the mucosa in detail and navigate the gastrointestinal tract efficiently. After the successful launch of aScope Duodeno 1.5, in February 2022, Ambu A/S announced that it had received FDA 510(k) clearance for its Ambu aScope Gastro and Ambu aBox 2, which are Ambu’s first sterile, single-use gastroscopes with updated imaging and design features. The single-use aScope Gastro solution, combined with the company's next-generation display and processing unit Ambu aBox 2, will help hospitals to perform quality and cost-effective gastroscopies at ease, across a wide range of care settings, such as endoscopy units, operating rooms (OR), intensive care units (ICU), emergency rooms (ER), and ambulatory surgery centers. In April 2021, Olympus Corporation announced the expansion of its respiratory portfolio by launching the first line of single-use bronchoscopes , the H-SteriScopes. The disposable bronchoscope is available in five models with premium features that help clinicians to target, diagnose, and treat patients while enhancing workflow and productivity. Speak To Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00004924 In May 2021, PENTAX Medical received CE mark for PENTAX Medical ONE Pulmo, a single-use bronchoscope with superior suction capacity and HD image quality. PENTAX Medical ONE Pulmo has features such as sterility with HD visualization, broadening the clinical applications beyond the standard disposable scope. Thus, growing technological advancements and product launches of disposable endoscopes will propel the disposable endoscope market growth during the forecast period. Based on application, the disposable endoscope market is segmented into urologic endoscopy, GI endoscopy, bronchoscopy, arthroscopy, proctoscopy, and others. The GI endoscopy segment held the largest share of the market in 2022. However, the urologic endoscopy segment is expected to register the highest CAGR during the forecast period. In terms of end user, the disposable endoscope market is segmented into hospitals, diagnostics centers, and clinics. The hospitals segment held the largest market share in 2022 and is likely to continue its dominance during the forecast period. Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount): Sinuscopes Endoscope Market Forecast to 2028 - Covid-19 Impact and Global Analysis Duodenal Endoscope Market Forecast to 2028 - COVID-19 Impact and Global Analysis

Ambu Acquisitions

3 Acquisitions

Ambu acquired 3 companies. Their latest acquisition was Invendo Medical on October 25, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/25/2017

Series B

$99M

$36.6M

Acquired

1

9/28/2016

Subscribe to see more

$99M

Subscribe to see more

10

12/22/2008

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

10/25/2017

9/28/2016

12/22/2008

Investment Stage

Series B

Other Venture Capital

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

$36.6M

$99M

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

10

0

Ambu Partners & Customers

10 Partners and customers

Ambu has 10 strategic partners and customers. Ambu recently partnered with Frost & Sullivan on March 3, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

3/2/2021

Client

United States

Ambu Named Frost & Sullivan ‘New Product Innovation Award’ Winner for Single-use Flexible Endoscopy

Frost & Sullivan selected Ambu due to its work in single-use flexible endoscopy where Ambu is creating an innovation paradigm shift by rapidly bringing new technologies and products in shorter life cycles .

1

11/23/2020

Client

United States

Ambu ACTion™ Block Pain Pump Available to Intalere Members Through New Group Purchasing Agreement

COLUMBIA , Md. -- -- Ambu Inc. , the world leader in single-use medical devices , has reached a new agreement with Intalere for pain care management solutions .

1

6/30/2020

Partner

United States

Ambu, Fuel Medical ink partnership deal - MassDevice

Ambu announced that it entered into a partnership with Fuel Medical Group to combine marketing and strategy with the latter 's endoscope technologies .

2

12/20/2019

Supplier

United States

Subscribe to see more

Subscribe to see more

10

5/18/2019

Licensee

United States

Subscribe to see more

Subscribe to see more

10

Date

3/2/2021

11/23/2020

6/30/2020

12/20/2019

5/18/2019

Type

Client

Client

Partner

Supplier

Licensee

Business Partner

Country

United States

United States

United States

United States

United States

News Snippet

Ambu Named Frost & Sullivan ‘New Product Innovation Award’ Winner for Single-use Flexible Endoscopy

Frost & Sullivan selected Ambu due to its work in single-use flexible endoscopy where Ambu is creating an innovation paradigm shift by rapidly bringing new technologies and products in shorter life cycles .

Ambu ACTion™ Block Pain Pump Available to Intalere Members Through New Group Purchasing Agreement

COLUMBIA , Md. -- -- Ambu Inc. , the world leader in single-use medical devices , has reached a new agreement with Intalere for pain care management solutions .

Ambu, Fuel Medical ink partnership deal - MassDevice

Ambu announced that it entered into a partnership with Fuel Medical Group to combine marketing and strategy with the latter 's endoscope technologies .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

Ambu Team

12 Team Members

Ambu has 12 team members, including current Chief Executive Officer, Juan Jose Gonzalez.

Name

Work History

Title

Status

Juan Jose Gonzalez

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Juan Jose Gonzalez

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.